Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Einhorn, Lawrence H.Adra, NabilHanna, NasserNichols, Craig2021-09-212021-09-212020-09Einhorn, L. H., Adra, N., Hanna, N., & Nichols, C. (2020). Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(26), 3073–3074. https://doi.org/10.1200/JCO.20.00702https://hdl.handle.net/1805/26634enadjuvant chemotherapyadjuvant etoposide plus cisplatinAdjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?Article